Moreover, in breast cancer patients, compared to normal breast tissue and para-tumor tissues, HTR6 expression was increased in in situ breast cancer, but decreased in invasive breast cancer, and almost no expression was found in distal and lymphatic metastases, showing a trend wave during the development of breast cancer. The gene discussed is HTR6; the disease is breast carcinoma in situ.